Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations

v2.4.0.6
Condensed Statements of Operations (USD $)
3 Months Ended 6 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2012
Dec. 31, 2011
Revenues   $ 233,832 $ 390,186 $ 554,180
Operating expenses:        
Research and development 655,783 1,162,320 1,833,318 2,618,960
General and administrative 1,039,388 1,745,156 2,062,057 2,933,890
Totals 1,695,171 2,907,476 3,895,375 5,552,850
Operating loss (1,695,171) (2,673,644) (3,505,189) (4,998,670)
Other income (expense):        
Interest income 2,390 608 5,862 2,206
Interest expense (17,451) (16,800) (32,858) (26,376)
Royalty income 3,970 5,408 15,379 17,063
Change in the fair value of derivative financial liability 635,108 1,086,768 394,225 3,791,260
Totals 624,017 1,075,984 382,608 3,784,153
Net loss $ (1,071,154) $ (1,597,660) $ (3,122,581) $ (1,214,517)
Net loss per common share - basic and diluted (in Dollars per share) $ (0.02) $ (0.05) $ (0.07) $ (0.04)
Weighted average common shares outstanding – basic and diluted (in Shares) 47,767,095 32,382,095 47,767,095 32,382,095